Related Experiment Video

Updated: May 9, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Acute treatment of anaphylaxis in children

Ran D Goldman1

  • 1BC Children's Hospital, Department of Pediatrics, Room K4-226, Ambulatory Care Bldg, 4480 Oak St, Vancouver, BC V6H 3V4. rgoldman@cw.bc.ca

Canadian Family Physician Medecin De Famille Canadien
|July 16, 2013
PubMed

Insights

The best treatment for childhood anaphylaxis is intramuscular epinephrine injection. Children with severe allergies should always carry an epinephrine autoinjector and be educated on its proper use.

Area of Science:

  • Pediatric Allergy and Immunology
  • Emergency Medicine

Background:

  • Anaphylaxis is a severe, life-threatening allergic reaction.
  • Prompt recognition and treatment are crucial for positive outcomes in children.

Purpose of the Study:

  • To determine the optimal treatment for pediatric anaphylaxis.
  • To assess the necessity and proper use of epinephrine autoinjectors in children experiencing allergic reactions.

Main Methods:

  • Case presentation of a 3-year-old child experiencing anaphylaxis after nut ingestion.
  • Review of current treatment guidelines for anaphylaxis in pediatric patients.

Main Results:

  • Intramuscular epinephrine injection is confirmed as a safe and effective first-line treatment for pediatric anaphylaxis.
  • Epinephrine autoinjectors are recommended for immediate use during systemic allergic reactions.

Conclusions:

  • Children with a history of anaphylaxis must carry epinephrine autoinjectors consistently, including at school.
  • Education on the correct usage and expiration dates of epinephrine autoinjectors is vital for families and children.
Abstract

More Related Videos

Measuring Local Anaphylaxis in Mice07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: